"Eric Bowditch
developed a very effective out-licensing program for KindaPed in
head lice. Eric's systematic approach to licensing and
targeting, developing out-licensing materials and his
comprehensive network of pharma contacts opened many doors and
resulted in the successful European out-licensing of KindaPed to
a major European partner."
- Dr. Magnus Nicolson
Chief Executive, EctoPharma Ltd
"I have worked closely with Eric Bowditch at ProStrakan plc since 1998 on a number of business
development and licensing projects. He was instrumental in the
out-licensing of Zindaclin in Europe and on the Sancuso
licensing agreement with MPM Capital/Japan Bridge. Eric has
developed a very effective systematic approach to licensing with
a high rate of success. I can vouch for his honesty, integrity
and professionalism in business development and licensing. Eric
remains a US business development consultant for ProStrakan."
- Thomas Stratford Ph.D.
VP Global Business Development, ProStrakan
plc
"Rarely have I encountered a more
proactive, rigorous and responsive business development
professional. Eric Bowditch's systematic approach to licensing and
efficient targeting systems open up more doors, save more time,
consume less resources, and close more deals than most other
consultants out there. Eric can be the difference between
success and failure for start-ups and a breath of fresh air for
intermediate size and specialty pharma companies."
- Ashleigh Palmer
Chief Executive Officer, Critical
Biologics Corporation
"Eric Bowditch has worked closely
with ULURU Inc. in business development & licensing since the
company was founded in October 2005. He ran a very effective
out-licensing program for OraDisc A (amlexanox) which was
out-licensed to Meda AB, Europe and OraDisc B (benzocaine) to
Meldex International for Europe/Middle East. I can vouch for
Eric's professionalism and integrity in business development and
licensing. Eric continues to be actively involved in partnering
programs at ULURU Inc."
- Renaat Van den Hooff
President & CEO, ULURU Inc.
"I have known Eric Bowditch since
1987 both as a consultant and employer. I can vouch for his
integrity and experienced professionalism in business
development and licensing. Eric developed a very effective
European and North American out-licensing program for Zindaclin
in acne with a deal structure which was very beneficial to
Strakan (now ProStrakan plc). Eric's systematic approach to
licensing and responsiveness enables deals to be closed with
speed and efficiency."
- Harry Stratford, OBE
Founder, Shire Pharmaceuticals &
ProStrakan plc
"I first met Eric Bowditch in
1987 and worked closely with him at Shire Pharmaceuticals on a
number of business development projects. In 2003, Eric joined
the advisory team at Hunter-Fleming Ltd. I can vouch for his
honesty, integrity and his experienced professionalism in
business development and licensing. Eric was a consultant with
Hunter-Fleming until 2008 when the company was acquired by
Newron Pharmaceuticals. Eric assisted the company in a number of
business development projects and financing. His rigorous and
systematic approach to licensing leads to a high rate of success
in closing agreements."
- James R. Murray, M.D.
Founder, Hunter-Fleming Ltd.
"I have known Eric Bowditch since
1996 both as a colleague and his employee. I have worked in
various scientific capacities with him on numerous business
development and licensing projects. He has always brought
energy, integrity and professionalism to every project. He
consistently impressed me with his ability to approach each
project with a systemic and creative “think out of the box”
approach to achieve goals that are in the best interest of his
clients."
- Richard G. Van Inwegen, PhD
Director of Operations, Analgesic Research
Inc.
"I have worked with Eric Bowditch
since 2003 on multiple projects ranging from anti-cancer
technologies through to consumer pharmaceuticals. Throughout,
Eric has been the consummate professional with a wide knowledge
and experience in pharmaceutical technology, licensing and
business development functions. By using clear objectives for
all parties, he always creates a process that is efficient and
transparent resulting in “getting the job done” along with a
long-term and fruitful relationship."
- SJ
Martin
Chief Executive, Penlan Healthcare Ltd
|
|
"Eric's systematic approach to licensing and responsiveness
enables deals to be closed with speed and efficiency."
- Harry Stratford, OBE
Founder, Shire Pharmaceuticals & ProStrakan plc
"I can vouch for Eric's honesty, integrity and his
experienced professionalism in business development and
licensing."
- James R. Murray, M.D.
Founder, Hunter-Fleming Ltd. |
